The Role of ZNF275/AKT Pathway in Carcinogenesis and Cisplatin Chemosensitivity of Cervical Cancer Using Patient-Derived Xenograft Models

Zinc finger protein 275 (ZNF275) is a C2H2-type transcription factor that is localized on chromosome Xq28. Whether ZNF275 participates in modulating the biological behaviors of cervical cancer has not been determined to our knowledge. The present study employed CCK-8, BrdU, flow cytometry, and a tra...

Full description

Bibliographic Details
Main Authors: Miaomiao Ye, Tingxian Liu, Liqing Miao, Shuangwei Zou, Huihui Ji, Jian’an Zhang, Xueqiong Zhu
Format: Article
Language:English
Published: MDPI AG 2023-11-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/15/23/5625
_version_ 1797400397701185536
author Miaomiao Ye
Tingxian Liu
Liqing Miao
Shuangwei Zou
Huihui Ji
Jian’an Zhang
Xueqiong Zhu
author_facet Miaomiao Ye
Tingxian Liu
Liqing Miao
Shuangwei Zou
Huihui Ji
Jian’an Zhang
Xueqiong Zhu
author_sort Miaomiao Ye
collection DOAJ
description Zinc finger protein 275 (ZNF275) is a C2H2-type transcription factor that is localized on chromosome Xq28. Whether ZNF275 participates in modulating the biological behaviors of cervical cancer has not been determined to our knowledge. The present study employed CCK-8, BrdU, flow cytometry, and a transwell assay to investigate the cell viability, proliferation, apoptosis, migration, and invasion of cervical cancer cells. The application of Western blotting and immunohistochemistry (IHC) aims to assess ZNF275 protein expression and identify the signaling pathway relevant to ZNF275-mediated effects on cervical cancer. The therapeutic impact of the combined therapy of the AKT inhibitor triciribine and cisplatin was evaluated on cervical cancer patient-derived xenograft (PDX) models expressing high ZNF275. The current research illustrated that cervical cancer tissue exhibited a higher expression of ZNF275 in contrast to the surrounding normal cervical tissue. The downregulation of ZNF275 suppressed cell viability, migration, and invasion, and facilitated the apoptosis of SiHa and HeLa cells via weakening AKT/Bcl-2 signaling pathway. Moreover, triciribine synergized with cisplatin to reduce cell proliferation, migration, and invasion, and enhanced the apoptosis of SiHa cells expressing high ZNF275. In addition, the combination treatment of triciribine and cisplatin was more effective in inducing tumor regression than single agents in cervical cancer PDX models expressing high ZNF275. Collectively, the current findings demonstrated that ZNF275 serves as a sufficiently predictive indicator of the therapeutic effectiveness of the combined treatment of triciribine and cisplatin on cervical cancer. Combining triciribine with cisplatin greatly broadens the therapeutic options for cervical cancer expressing high ZNF275, but further research is needed to confirm these results.
first_indexed 2024-03-09T01:54:04Z
format Article
id doaj.art-a288e375ab7e491081a7d3fe7a4eb61c
institution Directory Open Access Journal
issn 2072-6694
language English
last_indexed 2024-03-09T01:54:04Z
publishDate 2023-11-01
publisher MDPI AG
record_format Article
series Cancers
spelling doaj.art-a288e375ab7e491081a7d3fe7a4eb61c2023-12-08T15:12:45ZengMDPI AGCancers2072-66942023-11-011523562510.3390/cancers15235625The Role of ZNF275/AKT Pathway in Carcinogenesis and Cisplatin Chemosensitivity of Cervical Cancer Using Patient-Derived Xenograft ModelsMiaomiao Ye0Tingxian Liu1Liqing Miao2Shuangwei Zou3Huihui Ji4Jian’an Zhang5Xueqiong Zhu6Zhejiang Provincial Clinical Research Center for Obstetrics and Gynecology, Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou 325027, ChinaZhejiang Provincial Clinical Research Center for Obstetrics and Gynecology, Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou 325027, ChinaZhejiang Provincial Clinical Research Center for Obstetrics and Gynecology, Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou 325027, ChinaZhejiang Provincial Clinical Research Center for Obstetrics and Gynecology, Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou 325027, ChinaZhejiang Provincial Clinical Research Center for Obstetrics and Gynecology, Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou 325027, ChinaZhejiang Provincial Clinical Research Center for Obstetrics and Gynecology, Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou 325027, ChinaZhejiang Provincial Clinical Research Center for Obstetrics and Gynecology, Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou 325027, ChinaZinc finger protein 275 (ZNF275) is a C2H2-type transcription factor that is localized on chromosome Xq28. Whether ZNF275 participates in modulating the biological behaviors of cervical cancer has not been determined to our knowledge. The present study employed CCK-8, BrdU, flow cytometry, and a transwell assay to investigate the cell viability, proliferation, apoptosis, migration, and invasion of cervical cancer cells. The application of Western blotting and immunohistochemistry (IHC) aims to assess ZNF275 protein expression and identify the signaling pathway relevant to ZNF275-mediated effects on cervical cancer. The therapeutic impact of the combined therapy of the AKT inhibitor triciribine and cisplatin was evaluated on cervical cancer patient-derived xenograft (PDX) models expressing high ZNF275. The current research illustrated that cervical cancer tissue exhibited a higher expression of ZNF275 in contrast to the surrounding normal cervical tissue. The downregulation of ZNF275 suppressed cell viability, migration, and invasion, and facilitated the apoptosis of SiHa and HeLa cells via weakening AKT/Bcl-2 signaling pathway. Moreover, triciribine synergized with cisplatin to reduce cell proliferation, migration, and invasion, and enhanced the apoptosis of SiHa cells expressing high ZNF275. In addition, the combination treatment of triciribine and cisplatin was more effective in inducing tumor regression than single agents in cervical cancer PDX models expressing high ZNF275. Collectively, the current findings demonstrated that ZNF275 serves as a sufficiently predictive indicator of the therapeutic effectiveness of the combined treatment of triciribine and cisplatin on cervical cancer. Combining triciribine with cisplatin greatly broadens the therapeutic options for cervical cancer expressing high ZNF275, but further research is needed to confirm these results.https://www.mdpi.com/2072-6694/15/23/5625cervical cancerzinc finger protein 275 (ZNF275)cisplatinchemosensitivitypatient-derived xenograft (PDX) models
spellingShingle Miaomiao Ye
Tingxian Liu
Liqing Miao
Shuangwei Zou
Huihui Ji
Jian’an Zhang
Xueqiong Zhu
The Role of ZNF275/AKT Pathway in Carcinogenesis and Cisplatin Chemosensitivity of Cervical Cancer Using Patient-Derived Xenograft Models
Cancers
cervical cancer
zinc finger protein 275 (ZNF275)
cisplatin
chemosensitivity
patient-derived xenograft (PDX) models
title The Role of ZNF275/AKT Pathway in Carcinogenesis and Cisplatin Chemosensitivity of Cervical Cancer Using Patient-Derived Xenograft Models
title_full The Role of ZNF275/AKT Pathway in Carcinogenesis and Cisplatin Chemosensitivity of Cervical Cancer Using Patient-Derived Xenograft Models
title_fullStr The Role of ZNF275/AKT Pathway in Carcinogenesis and Cisplatin Chemosensitivity of Cervical Cancer Using Patient-Derived Xenograft Models
title_full_unstemmed The Role of ZNF275/AKT Pathway in Carcinogenesis and Cisplatin Chemosensitivity of Cervical Cancer Using Patient-Derived Xenograft Models
title_short The Role of ZNF275/AKT Pathway in Carcinogenesis and Cisplatin Chemosensitivity of Cervical Cancer Using Patient-Derived Xenograft Models
title_sort role of znf275 akt pathway in carcinogenesis and cisplatin chemosensitivity of cervical cancer using patient derived xenograft models
topic cervical cancer
zinc finger protein 275 (ZNF275)
cisplatin
chemosensitivity
patient-derived xenograft (PDX) models
url https://www.mdpi.com/2072-6694/15/23/5625
work_keys_str_mv AT miaomiaoye theroleofznf275aktpathwayincarcinogenesisandcisplatinchemosensitivityofcervicalcancerusingpatientderivedxenograftmodels
AT tingxianliu theroleofznf275aktpathwayincarcinogenesisandcisplatinchemosensitivityofcervicalcancerusingpatientderivedxenograftmodels
AT liqingmiao theroleofznf275aktpathwayincarcinogenesisandcisplatinchemosensitivityofcervicalcancerusingpatientderivedxenograftmodels
AT shuangweizou theroleofznf275aktpathwayincarcinogenesisandcisplatinchemosensitivityofcervicalcancerusingpatientderivedxenograftmodels
AT huihuiji theroleofznf275aktpathwayincarcinogenesisandcisplatinchemosensitivityofcervicalcancerusingpatientderivedxenograftmodels
AT jiananzhang theroleofznf275aktpathwayincarcinogenesisandcisplatinchemosensitivityofcervicalcancerusingpatientderivedxenograftmodels
AT xueqiongzhu theroleofznf275aktpathwayincarcinogenesisandcisplatinchemosensitivityofcervicalcancerusingpatientderivedxenograftmodels
AT miaomiaoye roleofznf275aktpathwayincarcinogenesisandcisplatinchemosensitivityofcervicalcancerusingpatientderivedxenograftmodels
AT tingxianliu roleofznf275aktpathwayincarcinogenesisandcisplatinchemosensitivityofcervicalcancerusingpatientderivedxenograftmodels
AT liqingmiao roleofznf275aktpathwayincarcinogenesisandcisplatinchemosensitivityofcervicalcancerusingpatientderivedxenograftmodels
AT shuangweizou roleofznf275aktpathwayincarcinogenesisandcisplatinchemosensitivityofcervicalcancerusingpatientderivedxenograftmodels
AT huihuiji roleofznf275aktpathwayincarcinogenesisandcisplatinchemosensitivityofcervicalcancerusingpatientderivedxenograftmodels
AT jiananzhang roleofznf275aktpathwayincarcinogenesisandcisplatinchemosensitivityofcervicalcancerusingpatientderivedxenograftmodels
AT xueqiongzhu roleofznf275aktpathwayincarcinogenesisandcisplatinchemosensitivityofcervicalcancerusingpatientderivedxenograftmodels